Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 5/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | STAT1 | P42224 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573973 | 1.00 | KMT2A (0.57) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| SCHEMBL13620914 | 0.88 | KMT2A (0.58) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| SCHEMBL29034428 | 0.79 | KMT2A (0.57) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| SCHEMBL6212079 | 0.77 | MEN1 (0.52) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| SCHEMBL14008076 | 0.77 | PTGER1 (0.58) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| SCHEMBL4923103 | 0.76 | PTGER1 (0.68) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| SCHEMBL4029373 | 0.76 | MEN1 (0.60) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| SCHEMBL6213049 | 0.75 | CCR5 (0.48) | KMT2AMRGPRX4RAB9ANPC1CCR5 | |
| SCHEMBL4919353 | 0.74 | PTGER1 (0.52) | KMT2AMEN1ALDH1A1MRGPRX4RAB9A | |
| Hydrochloric Acid SCHEMBL6213801 | 0.74 | MEN1 (0.50) | KMT2AMEN1MRGPRX4RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281126-A1 | Organic Compounds | NOVARTIS AG | 2009-11-12 | — | — | US | disclosed |
| CN-101426785-A | Adenosine A3 receptor agonists | NOVARTIS AG (CH) | 2009-05-06 | — | — | CN | disclosed |
| EP-2013199-A1 | ADENOSINE A3 RECEPTOR AGONISTS | Novartis AG (CH) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007147659-A1 | ADENOSINE A3 RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2007-12-27 | — | — | WO | disclosed |
| EP-1216257-B1 | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | PFIZER PROD INC (US) | 2005-12-07 | — | — | EP | disclosed |
| US-6803457-B1 | ADENOSINE RECEPTORS; FOR REDUCTION OF TISSUE DAMAGE RESULTING FROM HYPOXIA/CARDIOVASCULAR DISORDERS IN MAMMALS/HUMANS | PFIZER, INC. | 2004-10-12 | — | — | US | disclosed |
| US-20040198693-A1 | Compounds for the treatment of ischemia | DENINNO MICHAEL P (US) | 2004-10-07 | — | — | US | disclosed |
| EP-1216257-A1 | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | Pfizer Products Inc. (US) | 2002-06-26 | — | — | EP | disclosed |
| WO-2001023399-A1 | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | PFIZER PRODUCTS INC. (US) | 2001-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281126-A1 | Organic Compounds | CYP3A43, CYP3A4, CYP2C19 | KMT2A 3422/4885MEN1 333/4885ALDH1A1 86/4885 |
| US-20040198693-A1 | Compounds for the treatment of ischemia | TNNI3, ADRB3, FABP3 | KMT2A 4722/4885MEN1 4830/4885ALDH1A1 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.